Fosravuconazole is under clinical development by Eisai and currently in Phase III for Fungal Infections. According to GlobalData, Phase III drugs for Fungal Infections have a 53% phase transition ...
After putting on surgical gloves, Matthew Allender gingerly picked up a Blanding’s turtle to inspect it for signs of a rare fungal pathogen. The fungus was recently discovered in the state-endangered ...